Multi-Center Human Alert Trial to Prevent DVT and PE
This study has been completed.
Sponsor:
Brigham and Women's Hospital
Collaborator:
Sanofi
Information provided by:
Brigham and Women's Hospital
ClinicalTrials.gov Identifier:
NCT00409136
First received: December 7, 2006
Last updated: January 29, 2009
Last verified: January 2009
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
To evaluate physician response to human alerts that inform the clinician that his/her patient may be eligible for thromboprophylaxis. Medical records are reviewed to evaluate prescribing decision and to evaluate rates of venous thromboembolism.
| Condition | Intervention |
|---|---|
|
Pulmonary Embolism Deep Vein Thrombosis Cancer Surgery |
Behavioral: Human Alert |
| Study Type: | Observational |
| Study Design: | Observational Model: Case Control Time Perspective: Prospective |
| Official Title: | Physician Alerts to Prevent DVT and Pulmonary Embolism in Hospitalized Patients |
Resource links provided by NLM:
Further study details as provided by Brigham and Women's Hospital:
Primary Outcome Measures:
- Clinically diagnosed DVT and/or PE [ Time Frame: 90 days ] [ Designated as safety issue: No ]
Secondary Outcome Measures:
- Mortality [ Time Frame: 30 and 90 days ] [ Designated as safety issue: No ]
- Hemorrhagic events [ Time Frame: 30 and 90 days ] [ Designated as safety issue: No ]
| Enrollment: | 2496 |
| Study Start Date: | March 2006 |
| Study Completion Date: | August 2008 |
| Primary Completion Date: | August 2008 (Final data collection date for primary outcome measure) |
| Groups/Cohorts | Assigned Interventions |
|---|---|
|
Alert
Physicians alerted about their high risk patients who are not receiving any VTE prophylaxis.
|
Behavioral: Human Alert
An alert from study staff informing a physician that his/her patient is at high risk for DVT and/or PE, but is not receiving any prophylaxis.
|
|
No Alert
Physicians not alerted about their high risk patients who are not receiving any VTE prophylaxis.
|
Behavioral: Human Alert
An alert from study staff informing a physician that his/her patient is at high risk for DVT and/or PE, but is not receiving any prophylaxis.
|
Show Detailed Description
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Probability Sample |
Study Population
Hospitalized patients that have a cumulative VTE risk score of 4 or more with no orders for prophylactic measures.
Criteria
Inclusion Criteria:
- Patients > 18 years of age
- Cumulative VTE risk score > 4
- Absence of pharmacologic or mechanical prophylaxis orders
- Patients from medical or surgical Services
Exclusion Criteria:
- VTE risk score <4
- Current active pharmacologic or mechanical prophylaxis order
- Patients from the Department of Neurology, Newborn Service, Rehab Units, and Neonatal Intensive Care Unit (NICU).
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00409136
Show 26 Study Locations
Show 26 Study LocationsSponsors and Collaborators
Brigham and Women's Hospital
Sanofi
Investigators
| Principal Investigator: | Samuel Z. Goldhaber, MD | Brigham and Women's Hospital |
More Information
Additional Information:
Publications:
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | Samuel Z. Goldhaber, MD, Brigham and Women's Hospital |
| ClinicalTrials.gov Identifier: | NCT00409136 History of Changes |
| Other Study ID Numbers: | 2005-P-002527 |
| Study First Received: | December 7, 2006 |
| Last Updated: | January 29, 2009 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Brigham and Women's Hospital:
|
Alert Deep Vein Thrombosis Pulmonary Embolism |
Venous Thromboembolism Prophylaxis Anticoagulation |
Additional relevant MeSH terms:
|
Embolism Pulmonary Embolism Thrombosis Venous Thrombosis Embolism and Thrombosis |
Vascular Diseases Cardiovascular Diseases Lung Diseases Respiratory Tract Diseases |
ClinicalTrials.gov processed this record on May 23, 2013